Akizuki, N., Uchida, S., Sasaki, S., and Marumo, F. (2001). Impaired solute accumulation in inner medulla of Clcnk1—/— mice kidney. Am. J. Physiol. Renal Physiol. 280, F79—F87. Arshinoff, S., McCulloch, J. C., Macrae, W., Stein, A. N., andMaliss, E. B. (1981). Amino acids in retinitis pigmentosa. Br. J. Ophthal. 65, 626—630.

Baum, M., and Weib, M. (2001). The influence of a taurine containing drink on cardiac parameters before and after exercise measured by echocardiography. Amino Acids 20, 75-82.

Belluzzi, O., Puopolo, M., Benedusi, M., and Kratskin, I. (2004). Selective neuroinhibitory effects of taurine in slices of rat main olfactory bulb. Neuroscience 124, 929-944.

Benini, G., Marconini, C., Wirth, A., and Montagnoli, G. (1988). Is taurine a marker for retinitis pigmentosa? Ophthalmologia 197, 130-135.

Bernardi, N. (1985). On the role of taurine in the cerebellar cortex: A reappraisal. Acta Physiol. Pharmacol. Latinoam. 35, 153-164.

Berry, G. T., Wu, S., Buccafusca, R., Ren, J., Gonzales, L. W., Ballard, P. L., Golden, J. A., Stevens, M. J., and Geer, J. J. (2003). Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J. Biol. Chem. 278,18297-18302.

Bitoun, M., Levillain, O., andTappaz, M. (2001). Gene expression of the taurine transporter and taurine biosynthetic enzymes in rat kidney after antidiuresis and salt loading. Pflüg. Arch. 442, 87-95.

Bureau, M. H., and Olsen, R. W. (1991). Taurine acts on a subclass of GABAa receptors in mammalian brain in vitro. Eur. J. Pharmacol. 207, 9-16.

Burg, M. H. (1995). Molecular basis of osmotic regulation. Am. J. Physiol. 268, F983-F996.

Butterworth, R. F. (2001). Neurotransmitter dysfunction in hepatic encephalopathy: New approaches and new findings. Metab. Brain Dis. 16, 55-65.

Cammarata, P. R., Zhou, C., Chen, G., Singh, I., Reeves, R. E., Kuszak, J. R., and Robinson, M. L. (1999). A transgenic animal model of osmotic cataract. 1. Overexpression of bovine Na+/myo-inositol cotransporter in lens fibers. Invest. Ophthlmol. Vis. Sci. 40, 1727-1737.

Chang, G. Q., Hao, Y., and Wong, F. (1993). Apoptosis: Final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 11, 595-605.

Chapman, R. A., Suleiman, M. S., and Earm, Y. E. (1993). Taurine and the heart. Cardiovasc. Res. 27, 358-363.

Chaput, M. A., Palouzier-Paulignan, B., Delaleu, J. C., and Duchamp-Viret, P. (2004). Taurine action on mitral cell activity in the frog olfactory bulb in vivo. Chem. Senses 29, 83-91.

Chau, J. F., Lee, M. K., Law, J. W., Chung, S. K., and Chung, S. S. (2005). Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEBJ. 19, 1887-1889.

Chepkova, A. N., Doreulee, N., Yanovsky, Y., Mukhopadhyay, D., Haas, H. L., and Sergeeva, O. A. (2002). Long-lasting enhancement of corticostriatal neurotransmission by taurine. Eur. J. Neurosci. 16, 1523-1530.

Chepkova, A. N., Sergeeva, O. A., and Haas, H. L. (2006). Taurine rescues hippocampal long-term potentiation from ammonia-induced impairment. Neurobiol. Dis. 23, 512-521.

Cowan, C. M., and Roskams, A.J. (2002). Apoptosis in the mature and developing olfactory neuroepithelium. Microsc. Res. Tech. 58, 204-215.

del Olmo, N., Bustamante, J., del Rio, R. M., and Solis, J. M. (2000). Taurine activates GABA(A) but not GABA(B) receptors in rat hippocampal CA1 area. Brain Res. 864, 298-307.

De Luca, A., Pierno, S., Tricarico, D., Desaphy, J. F., Liantonio, A., Barbieri, M., Camerino, C., Montanari, L., and Camerino, D. C. (2000). Taurine and skeletal muscle ion channels. Adv. Exp. Med. Biol. 483, 45-56.

El Idrissi, A., and Trenkner, E. (1999). Growth factors and taurine protect against excito-toxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci. 19, 9459-9468.

Farbman, A. I., Brunjes, P. C., Rentfro, L., Michas, J., and Ritz, S. (1988). The effect of unilateral naris occlusion on cell dynamics in the developing rat olfactory epithelium. J. Neurosci. 8, 3290-3295.

Gal, A., Apfelstedt-Sylla, E., Janecke, A. R., and Zrenner, E. (1997). Rhodopsin mutations in inherited retinal dystrophies and dysfunctions. Prog. Retinal Eye Res. 16, 51—79.

Garcia-Perez, A., and Burg, M. B. (1991). Renal medullary organic osmolytes. Physiol. Rev. 71, 1081-1115.

Graf, D., Kurz, A. K., Reinehr, R., Fischer, R., Kircheis, G., and Haussinger, D. (2002). Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology 36, 829-839.

Green, T. R., Fellman, J. H., Eicher, A. L., and Pratt, K. L. (1991). Antioxidant role and subcellular localization of hypotaurine and taurine in human neutrophils. Biochim. Biophys. Acta 1073, 91-97.

Haas, H. L., and Hosli, L. (1973). The depression of brain stem neurones by taurine and its interaction with strychnine and bicuculline. Brain Res. 52, 399-402.

Hayes, K. C., and Carey, R. E. (1975). Retinal degeneration associated with taurine deficiency in the cat. Science 188, 949-950.

Hediger, M. A., Smith, C. P., You, G., Lee, W. S., Kanai, Y., and Shayakul, C. (1996). Structure, regulation and physiological roles of urea transporters. Kidney Int. 49, 1615-1623.

Heller-Stilb, B., van Royen, C., Rascher, K., Hartwig, H. G., Huth, A., Seeliger, M. W., Warskulat, U., and Haussinger, D. (2002). Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J. 16, 231-233.

Huang, D. Y., Boini, K. M., Lang, P. A., Grahammer, F., Duszenko, M., Heller-Stilb, B., Warskulat, U., Haussinger, D., Lang, F., and Vallon, V. (2006). Impaired ability to increase water excretion in mice lacking the taurine transporter gene TAUT. Eur.

Humphries, M. M., Rancourt, D., Farrar, G. J., Kenna, P., Hazel, M., Bush, R. A., Sieving, P. A., Sheils, D. M., McNally, N., Creighton, P., Erven, A., Boros, A., et al. (1997). Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat. Genet. 15, 115-117.

Hussy, N., Deleuze, C., Pantaloni, A., Desarmenien, M. G., and Moos, F. (1997). Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: Possible role in osmoregulation. J. Physiol. 502, 609-621.

Huxtable, R.J. (1992). Physiological actions of taurine. Physiol. Rev. 72, 101-163.

Jiang, H., Ding, D., Muller, M., Pfister, M., Warskulat, U., Haussinger, D., and Salvi, R. (2005). Central auditory nerve degeneration in knockout mice lacking the taurine transporter. Meeting of the Association for Research in Otolaryngology, Daytona. [Abstract]

Jiang, Z., Chung, S. K., Zhou, C., Cammarata, P. R., and Chung, S. S. (2000). Overexpression of Na+-dependent myo-inositol transporter in mouse lens led to congenital cataract. Invest. Ophthlmol. Vis. Sci. 41, 1467-1472.

Kamisaki, Y., Wada, K., Nakamoto, K., and Itoh, T. (1996). Effects of taurine on GABA release from synaptosomes of rat olfactory bulb. Amino Acids 10, 49-57.

Kaneko, T., Takenaka, M., Okabe, M., Yoshimura, Y., Yamauchi, A., Horio, M., Kwon, H. M., Handler, J. S., and Lmai, E. (1997). Osmolarity in renal medulla of transgenic mice regulates transcription via 5'-flanking region of canine BGT1 gene. Am.

J. Physiol. 272, F610-F616.

Kratskin, I. L., Rio, J. P., Kenigfest, N. B., Doty, R. L., and Reperant, J. (2000). A light and electron microscopic study of taurine-like immunoreactivity in the main olfactory bulb of frogs. J. Chem. Neuroanat. 18, 87-101.

Kurz, A. K., Schliess, F., and Haussinger, D. (1998). Osmotic regulation of the heat shock response in primary hepatocytes. Hepatology 28, 774-781.

Kwon, M. H., and Handler, J. S. (1995). Cell volume regulated transporters of compatible osmolytes. Curr. Biol. 7, 465-471.

Lake, N. (1993). Loss of cardiac myofibrils: Mechanism of contractile deficits induced by taurine deficiency. Am. J. Physiol. 264, H1323—H1326.

Lake, N., and Verdone-Smith, C. (1989). Immuno-cytochemical localization of taurine in the mammalian retina. Curr. Eye Res. 8, 163—173.

Lang, F., Busch, G. L., Ritter, M., Volkl, H., Waldegger, S., Gulbins, E., and Haussinger, D. (1998). Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 78, 247-306.

Lang, P. A., Warskulat, U., Heller-Stilb, B., Huang, D. Y., Grenz, A., Myssina, S., Duszenko, M., Lang, F., Haussinger, D., Vallon, V., and Wieder, T. (2003). Blunted apoptosis of erythrocytes from taurine transporter deficient mice. Cell. Physiol. Biochem.

Liu, Q. R., Lopez-Corcuera, B., Nelson, H., Mandian, S., and Nelson, N. (1992). Cloning and expression of a cDNA encoding the transporter of taurine and b-alanine in mouse brain. Proc. Natl. Acad. Sci. USA 89, 12145-12149.

Lombardini, J. B. (1999). Taurine: Retinal function. Brain Res. Rev. 16, 151-169.

Magrassi, L., and Graziadei, P. P. (1995). Cell death in the olfactory epithelium. Anat. Embryol. (Berl.) 192, 77-87.

Mahalik, T. J. (1996). Apparent apoptotic cell death in the olfactory epithelium of adult rodents: Death occurs at different developmental stages. J. Comp. Neurol. 372, 457-464.

Mansour, S. L., Thomas, K. R., and Capecchi, M. R. (1988). Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes. Nature (London) 336, 348-352.

Medan, D., Wang, L., Toledo, D., Lu, B., Stehlik, C., Jiang, B. H., Shi, X., and Rojanasakul, Y. (2005). Regulation of Fas (CD95)-induced apoptotic and necrotic cell death by reactive oxygen species in macrophages. J. Cell Physiol. 203, 78-84.

Moise, N. S., Pacioretty, L. M., Kallfelz, F. A., Stipanuk, M. H., King, J. M., and Gilmour, R. F., Jr. (1991). Dietary taurine defiency dilated cardiomyopathy in the fox. Am. Heart J. 121, 541-547.

Mozaffari, M. S., and Schaffer, D. (2001). Taurine modulates arginine vasopressin-mediated regulation of renal function. J. Cardiovasc. Pharmacol. 37, 742-750.

Nakanishi, T., Uyama, O., Yamada, T., and Sugita, M. (1992). Sustained metabolic alkalosis associated with development of the milk-alkali syndrome. Nephron 60, 251.

Novotny, M. J., Hogan, P. M., Paley, D. M., and Adams, H. R. (1991). Systolic and diastolic dysfunction of the left ventricle induced by dietary taurine deficiency in cats. Am. J. Physiol. 261, H121-H127.

Obrosova, I. G., Fathallah, L., and Stevens, M. J. (2001). Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp. Neurol. 172, 211-219.

Oermann, E., Warskulat, U., Heller-Stilb, B., Haussinger, D., and Zilles, K. (2005). Taurine-transporter gene knockout-induced changes in GABAA, kainate and AMPA but not NMDA receptor binding in mouse brain. Anat. Embryol. 210, 363-372.

Park, E., Schuller-Levis, G., and Quinn, M. R. (1995). Taurine chloramine inhibits production of nitric oxide and TNF-m in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J. Immunol. 154, 4778-4784.

Pasantes-Morales, H., Dominguez, L., Compomanes, M. A., and Pacheco, P. (1986). Retinal degeneration induced by taurine deficiency in light-deprived cats. Exp. Eye Res. 43, 55-60.

Pasantes-Morales, H., Quiroz, H., and Quesada, O. (2002). Treatment with taurine, diltia-zem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: A 3-year follow-up study. Metab. Brain Dis. 17, 183-197.

Peters-Regehr, T., Bode, J. G., Kubitz, R., and Haussinger, D. (1999). Organic osmolyte transport in quiescent and activated rat hepatic stellate cells (Ito cells). Hepatology 29, 173-180.

Petrosian, A. M., and Haroutounian, J. E. (1998). The role of taurine in osmotic, mechanical, and chemical protection of the retinal rod outer segments. Adv. Exp. Med. Biol. 442, 407-413.

Petrosian, A. M., and Haroutounian, J. E. (2000). Taurine as a universal carrier of lipid soluble vitamins: A hypothesis. Amino Acids 19, 409-421.

Petrosian, A. M., Haroutounian, J. E., and Zueva, L. V. (1996). Tauret: A taurine-related endogenous substance in the retina and its role in vision. Adv. Exp. Med. Biol. 403, 333-342.

Pion, P. D., Kittleson, M. D., Rogers, Q. R., andMorris, J. G. (1987). Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy. Science 237, 764-768.

Pion, P. D., Kittleson, M. D., Thomas, W. P., Skiles, M. L., and Rogers, Q. R. (1992). Clinical findings in cats with dilated cardiomyopathy and relationship of findings to taurine deficiency. J. Am. Vet. Med. Assoc. 201, 167-274.

Portera-Cailliau, C., Sung, C. H., Nathans, J., and Adler, R. (1994). Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 91, 974-978.

Pow, D. V., Sullivan, R., Reye, P., and Hermanussen, S. (2002). Localization of taurine transporters, taurine, and (3)H taurine accumulation in the rat retina, pituitary, and brain.

GLIA 37, 153-168.

Ramamoorthy, S., Leibach, F. H., Mahesh, V. B., Han, H., Yang-Feng, T., Blakely, R. D., and Ganapathy, V. (1994). Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta. Biochem. J. 300, 893-900.

Rascher, K., Servos, G., Berthold, G., Hartwig, H., Warskulat, U., Heller-Stilb, B., and Haussinger, D. (2004). Light deprivation slows but does not prevent the loss of photoreceptors in taurine transporter knockout mice. Vision Res. 44, 2091-2100.

Reinehr, R., Becker, S., Hongen, A., and Haussinger, D. (2004a). The Scr family kinase Yes triggers hyperosmotic activation of the epidermal growth factor receptor and CD95. J. Biol. Chem. 279, 23977-23987.

Reinehr, R., Gorg, B., Hongen, A., and Haussinger, D. (2004b). CD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes. J. Biol.Chem. 279, 10364-10373.

Reinehr, R., Graf, D., and Haussinger, D. (2003a). Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 125, 839-853.

Reinehr, R., and Haussinger, D. (2006). Hyperosmotic activation of the CD95 death receptor system. Acta Physiol. (Oxf.) 187, 199-203.

Reinehr, R., Schliess, F., and Haussinger, D. (2003b). Hyperosmolarity and CD95L trigger CD95/EGFR association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation. FASEBJ. 17, 731-733.

Reme, C. E., Grimm, C., Hafezi, F., Marti, A., and Wenzel, A. (1998). Apoptotic cell death in retinal degenerations. Prog. Retinal Eye Res. 17, 443-464.

Saransaari, P., and Oja, S. S. (1991). Excitatory amino acids evoke taurine release from cerebral cortex slices from adult and developing mice. Neuroscience 45, 451-459.

Sawamura, A., Sada, H., Azuma, J., Kishimoto, S., and Sperelakis, N. (1990). Taurine modulates ion influx through cardiac Ca2+ channels. Cell. Calcium 11, 251-259.

Schaffer, S. W., and Azuma, J. (1992). Myocardial physiological effects of taurine and their significance. In "Taurine: Nutritional Value and Mechanisms ofAction'' (J. B. Lombardini, S. W. Schaffer, andJ. Azuma, eds.), pp. 105-120. Plenum Press, New York.

Scheller, D., Szathmary, S., Kolb, J., and Tegtmeier, F. (2000). Observations on the relationship between the extracellular changes of taurine and glutamate during cortical spreading depression, during ischemia, and within the area surrounding a thrombotic infarct. Amino Acids 19, 571—583.

Schloss, P., Puchel, A. W., and Betz, H. (1994). Neurotransmitter transporters: New members of known families. Curr. Opin. Cell Biol. 4, 595—599.

Schmidt, S. Y., Berson, E. L., and Hayes, K. C. (1976). Retinal degeneration in the taurine-deficient cat. Trans. Am. Acad. Ophthalmol. Otolaryngol. 81, OP687—OP693.

Schwob, J. E. (2002). Neural regeneration and the peripheral olfactory system. Anat. Rec. 269, 33-49.

Sergeeva, O. A., Chepkova, A. N., Doreulee, N., Eriksson, K. S., Poelchen, W., Monnighoff, I., Heller-Stilb, B., Warskulat, U., Haussinger, D., and Haas, H. L. (2003). Taurine-induced long-lasting enhancement of synaptic transmission in mice: Role of transporters. J. Physiol. 550, 911-919.

Sergeeva, O. A., and Haas, H. L. (2001). Expression and function of glycine receptors in striatal cholinergic interneurons from rat and mouse. Neuroscience 104, 1043-1055.

Shaldubina, A., Buccafusca, R., Johanson, R. A., Agam, G., Belmaker, R. H., Berry, G. T., and Bersudsky, Y. (2007). Behavioural phenotyping of sodium-myo-inositol cotrans-porter heterozygous knockout mice with reduced brain inositol. Genes Brain Behav. 6, 253-259.

Shayakul, C., and Hediger, M. A. (2004). The SLC14.gene family of urea transporters. Pflüg. Arch. 447, 603-609.

Smith, K. E., Borden, L. A., Wang, C. D., Hartig, P. R., Branchek, T. A., and Weinshank, R. L. (1992). Cloning and expression of a high affinity taurine transporter from rat brain. Mol. Pharmacol. 42, 563-569.

Stapleton, P. P., O'Flaherty, L., Redmond, P., and Bouchier-Hayes, D. J. (1998). Host defense: A role for the amino acid taurine? J. Parent. Ent. Nutr. 22, 42-48.

Timbrell, J. A., Saebra, V., and Waterfield, C. J. (1995). The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 26, 453-462.

Uchida, S., Kwon, H. M., Yamauchi, A., Preston, A. S., Marumo, F., and Handler, J. S. (1992). Molecular cloning of the cDNA for an MDCK cell Na+- and Cl~-dependent taurine transporter that is regulated by hypertonicity. Proc. Natl. Acad. Sci. USA 89, 8230-8234.

Uma, S. M., Satapathy, M., and Sitaramayya, A. (1983). Decreased plasma taurine levels in retinitis pigmentosa. Biochem. Med. 30, 49-52.

van Soest, S., Westerveld, A., DeJong, P., Bleeker-Wagemakers, E., andBergen, A. (1999). Retinitis pigmentosa: Defined from a molecular point of view. Surv. Ophthalmol. 43, 321-334.

Vinnakota, S., Qian, X., Egal, H., Sarthy, V., and Sarkar, H. K. (1997). Molecular characterization and in situ localization of a mouse retinal taurine transporter. J. Neurochem. 69, 2238-2250.

Warskulat, U., Andree, B., Lüsebrink, J., Kohrer, K., and Haussinger, D. (2006a). Switch from actin alpha 1 to alpha 2 expression and up-regulation of biomarkers for pressure overload and cardiac hypertrophy in taurine-deficient mouse heart. Biol. Chem. 387, 1449-1454.

Warskulat, U., Borsch, E., Reinehr, R., Heller-Stilb, B., Monnighoff, I., Buchczyk, D., Donner, M., Flogel, U., Kappert, G., Soboll, S., Beer, S., Pfeffer, K., et al. (2006b). Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEBJ. 20, 574-576.

Warskulat, U., Flogel, U., Jacoby, C., Hartwig, H. G., Thewissen, M., Merx, M. W., Molojavyi, A., Heller-Stilb, B., Schrader, J., and Haussinger, D. (2004). Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J. 18, 577-579.

Warskulat, U., Zhang, F., and Haussinger, D. (1997). Taurine is an osmolyte in rat liver macrophages (Kupffer cells). J. Hepatol. 26, 1340-1347.

Weik, C., Warskulat, U., Bode, J. G., Peters-Regehr, T., and Haussinger, D. (1998). Compatible organic osmolytes in rat liver sinusoidal endothelial cells. Hepatology 27, 569-575.

Weisdorf, S. A., Freese, D. K., Fath, J. J., Tsai, M. Y., and Cerra, F. B. (1987). Amino acid abnormalities in infants with extrahepatic biliary atresia and cirrhosis. J. Pediatr. Gastro-enterol. Nutr. 6, 860-864.

Welch, W. J., and Brown, R. (1996). Influence of molecular and chemical chaperones on protein folding. Cell Stress Chap. 1, 109-115.

Wettstein, M., and Haussinger, D. (1997). Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver. Hepatology 26, 1560-1566.

Witt, M., Roth, C., Warskulat, U., Bidmon, H. J., Haussinger, D., andHummel, T. (2003). Increased proliferation and chaperone activity in the olfactory mucosa of taurine transporter knockout mice. Chem. Senses 28, A108-A109.

Wong, P. (1994). Apoptosis, retinitis pigmentosa and degeneration. Biochem. Cell. Biol. 72, 489-498.

Wright, C. E., Tallan, H. H., Wright, T. R., Gillam, B., Gaull, G. E., and Sturman, J. A. (1987). Taurine availability and function in neurogenetic retinopathies. Adv. Exp. Med. Biol. 217, 101-112.

Yamamoto, S. (1996). Plasma taurine in liver cirrhosis with painful muscle cramps. Adv. Exp. Med. Biol. 403, 597-600.

Yancey, P. H., Clark, M. E., Hand, S. C., Bowlus, R. D., and Somero, G. N. (1975). Living with water stress: Evolution of osmolyte systems. Science 217, 1214-1222.

Yao, L., Huang, D. Y., Pfaff, I. L., Nie, X., Leitges, M., and Vallon, V. (2004). Evidence for a role of protein kinase C-alpha in urine concentration. Am. J. Physiol. Renal Physiol. 287, F299-F304.

Was this article helpful?

0 0

Post a comment